JPRN-UMIN000017417招募中未知
Clinical significance of urine-DPP-4 activity in patients with type2 diabetes. - Clinical significance of urine-DPP-4 activity in patients with type2 diabetes.
Second Department of Internal Medicine,Second Department of Internal Medicine0 个研究点目标入组 80 人开始时间: 2015年5月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.subjects who have severe renal dysfunction 2. subjects who have severe liver dysfunction 3. subjects who have insulin administration. 4. subjects who have malignant tumor. 5. expected, pregnant or lactating woman. 6. subjects to be inappropriate as an object of this examination by other reasons. And, medical staff and students.
研究者
相似试验
招募中
不适用
The clinical study to explore the effects of DPP-4 inhibitors on responses of lipidType 2 DiabetesJPRN-UMIN000020968Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine60
招募中
1 期
To explore the expression of DPP4 in patients with neuropathic paiITMCTR1900002381Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University
已完成
2 期
The effect of sitaglibtin (DPP4 inhibitor) administration in type 2 diabetes patients under insulin therapy regarding the weight, Lipid profile changes and blood glucose controlIRCT20191231045959N2Tabriz University of Medical Sciences60
进行中（未招募）
不适用
Quantification of the DPP-4 inhibition-mediated enhancement of the activity of the entero-insular axisDiabetes Type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-001663-11-DEDiabeteszentrum Bad Lauterberg
已完成
不适用
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney diseaseJPRN-UMIN000018464ihon University School of Medicine100